Viewing Study NCT00700193


Ignite Creation Date: 2025-12-25 @ 1:21 AM
Ignite Modification Date: 2026-01-04 @ 4:07 PM
Study NCT ID: NCT00700193
Status: COMPLETED
Last Update Posted: 2016-07-19
First Post: 2008-06-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of the Safety, Tolerability & Immunogenicity of CSL Limited's Influenza Virus Vaccine In a Paediatric Population
Sponsor: Seqirus
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module